Written Question · S4W-10031 · Session 4
Further to the answer to question S4O-01319 by Alex Neil on 26 September 2012 (Official Report, c. 11901), how it will address the issue of…
The question
To ask the Scottish Government, further to the answer to question S4O-01319 by Alex Neil on 26 September 2012 (Official Report, c. 11901), how it will address the issue of achieving greater consistency across the country when making decisions regarding individual patient treatment requests.
The answer
The guidance issued to NHS boards on 18 March 2011 under cover of CEL 17 (2010) provided a framework within which NHS boards should, as a matter of good practice, operate when dealing with requests for medicine which have been appraised within their licensed indication but have not been recommended for use within NHSScotland. The key purpose of the guidance was to achieve consistency of approach across all NHS boards in Scotland in relation to management of IPTRs for such medicines for individual patients.
The Scottish Government recognises that NHS boards may make different decisions on IPTRs for medicines as these are considered locally on a “case-by-case” basis depending on the individual clinical circumstances of the patient which will vary from patient to patient.
The guidance issued to NHS boards on 13 February 2012 under cover of SGHD/CMO(2012)1 which took effect on 1 April 2012, recognised the benefits of NHS boards meeting at least annually to share good practice in relation to IPTR management. As part of the Scottish Government’s ongoing commitment to monitoring implementation of CEL 17 (2010) and subsequent guidance, NHS boards will be encouraged to meet to share good practice.
The Scottish Government recognises that NHS boards may make different decisions on IPTRs for medicines as these are considered locally on a “case-by-case” basis depending on the individual clinical circumstances of the patient which will vary from patient to patient.
The guidance issued to NHS boards on 13 February 2012 under cover of SGHD/CMO(2012)1 which took effect on 1 April 2012, recognised the benefits of NHS boards meeting at least annually to share good practice in relation to IPTR management. As part of the Scottish Government’s ongoing commitment to monitoring implementation of CEL 17 (2010) and subsequent guidance, NHS boards will be encouraged to meet to share good practice.
In the Official Report
No contribution in the Official Report cites S4W-10031 by reference.